Facebook Users

Will CLZR go up?

CLZR Candela Corporation featured news, full reports, and detailed charts

Candela Corporation (CLZR) Wrap Up:

Candela Corporation (“Candela” or the “Company”) is a pioneer in the development and commercialization of advanced aesthetic laser and light-based systems that allow physicians and personal care practitioners to treat a wide variety of cosmetic and medical conditions including: † permanent hair reduction on all skin types; † skin rejuvenation, skin tightening and wrinkle reduction; † vascular lesions such as rosacea, facial spider veins, leg veins, port wine stains, angiomas and hemangiomas; † all-color tattoo removal; skin resurfacing scars, stretch marks and warts; † removal of benign pigmented lesions such as sun spots, age spots, freckles, and Nevus of Ota/Ito; † acne and acne scars; † sebaceous hyperplasia; † beard bumps (PFB); † psoriasis; and, † other cosmetic skin treatments. Since our founding 37 years ago, we have continuously developed and enhanced applications for laser and light-based technology.  ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2007%2f09%2f13%2f0001104659-07-068928.html#FIS_BUSINESS"   
www.candelalaser.com
363 Employees
Founded in 1969

Candela Corporation (CLZR:NASDAQ)

LAST $2.89 USD
CHANGE TODAY -0.06 -2.03%
VOLUME 24.8K
As of 3:59 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).

Snapshot of Candela Corporation (CLZR)

OPEN
$2.93
PREVIOUS CLOSE
$2.95
DAY HIGH
$2.95
DAY LOW
$2.87
52 WEEK HIGH
11/5/09 - $3.55
52 WEEK LOW
03/9/09 - $0.27
MARKET CAP
66.2M
AVERAGE VOLUME 3 mo
127.9K
DILUTED EPS TTM
$-0.47
SHARES OUTSTANDING
22.9M
CLZR Does Not Pay Dividends
P/E TTM
NM
K = Thousands  M = Millions  B = Billions

CLZR Top Compensated Officers

Mr. Gerard E. Puorro
Chief Executive Officer, President, Director ...
Age: 62
Total Annual Compensation: $516.1K
Mr. Robert E. Quinn
Chief Financial Officer, Acting Principal Acc...
Age: 55
Total Annual Compensation: $182.1K
Mr. Jay D. Caplan BSEE MBA
Chief Operating Officer
Age: 47
Total Annual Compensation: $319.2K
Mr. Dennis S. Herman
Senior Vice President of North American Sales...
Age: 59
Total Annual Compensation: $258.3K
Mr. Paul R. Lucchese Esq.
Senior Vice President, Corporate Secretary an...
Age: 43
Total Annual Compensation: $215.6K

Executives, Board Directors

Compensation as of Fiscal Year 2009.

Key developments for Candela Corporation (CLZR)

Candela Corp. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended September 26, 2009

Candela Corp. reported unaudited consolidated earnings results for the first quarter ended September 26, 2009. The company reported that revenues for the quarter ended September 26, 2009 were $26.2 million compared to $26.665 million for the same period of last year. Net loss for the quarter was $3,627,000 or $0.16 per basic and diluted share compared to net loss of $4,009,000 or $0.18 per basic and diluted share for the same period of last year. The current quarter results include approximately $2.3 million of expenses related to merger efforts. The company reported loss from operations of $4.864 million, loss from continuing operations before income taxes of $4.644 million and loss from continuing operations of $3.584 million or $0.16 per basic and diluted share compared to loss from operations of $6.531 million, loss from continuing operations before income taxes of $6.605 million and loss from continuing operations of $3.519 million or $0.16 per basic and diluted share for the same period of last year.

Candela Corp. expected to Report Q2 2010 Results on January 18, 2010. This event was calculated by Capital IQ (Created on October 20, 2009).

Candela Corp. expected to Report Q2 2010 Results on January 18, 2010. This event was calculated by Capital IQ (Created on October 20, 2009).

Holzer Holzer & Fistel, LLC Files Class Action Lawsuit Against Candela Corp

Holzer Holzer & Fistel, LLC announced a shareholder class action lawsuit has been filed against Candela Corp. and certain of its directors alleging violations of state law in connection with the buyout of the company by Syneron Medical Ltd. According to the complaint, Candela shareholders will receive 0.2911 shares of Syneron in exchange for each Candela share they own. The complaint alleges Candela's directors breached their fiduciary duty by approving the buyout for inadequate consideration. Further, the complaint alleges Candela's directors breached their fiduciary duties by failing to employ an adequate process to evaluate the transaction.

otc, otcbb, pinksheet, CLZR, ob Candela Corporation

CLZR Competitors

Company Last Change
Cutera Inc $9.08 USD +0.02
Cynosure Inc $10.06 USD +0.07
IRIDEX Corp $2.79 USD +0.01
Solta Medical Inc $2.24 USD -0.03
Spectranetics Corp $6.01 USD +0.16
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation CLZR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book 0.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x

CLZR

 | 

CLZR transactions

Type
Date
Target
Merger/Acquisition
September 8, 2009
--

More Recent News About Candela Corporation

Would you like to leave a comment about Candela Corporation CLZR

Besides Candela Corporation there is more great information available at Realpennies.com